LinkedIn

 آمار

تعداد نشریات20
تعداد شماره‌ها1,113
تعداد مقالات10,208
تعداد مشاهده مقاله40,780,201
تعداد دریافت فایل اصل مقاله8,803,967
Negahdaripour, Manica. (1399). COVID-19 Vaccine Global Access Is an Urgency. سامانه مدیریت نشریات علمی, 46(2), 79-80. doi: 10.30476/ijms.2021.47336
Manica Negahdaripour. "COVID-19 Vaccine Global Access Is an Urgency". سامانه مدیریت نشریات علمی, 46, 2, 1399, 79-80. doi: 10.30476/ijms.2021.47336
Negahdaripour, Manica. (1399). 'COVID-19 Vaccine Global Access Is an Urgency', سامانه مدیریت نشریات علمی, 46(2), pp. 79-80. doi: 10.30476/ijms.2021.47336
Negahdaripour, Manica. COVID-19 Vaccine Global Access Is an Urgency. سامانه مدیریت نشریات علمی, 1399; 46(2): 79-80. doi: 10.30476/ijms.2021.47336

COVID-19 Vaccine Global Access Is an Urgency

Iranian Journal of Medical Sciences
مقاله 1، دوره 46، شماره 2، خرداد 2021، صفحه 79-80    اصل مقاله (138.14 K)
نوع مقاله: Editorial
شناسه دیجیتال (DOI): 10.30476/ijms.2021.47336
نویسنده
Manica Negahdaripour* 1، 2
1Pharmaceutical Sciences Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
2Department of Pharmaceutical Biotechnology, School of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran
چکیده
After almost one year of intense global struggle with SARS-CoV-2 since its first report in Dec. 2019, the introduction of several vaccines for COVID-19 prevention has revived hopes in many people around the world. Several vaccines already approved or started to use in different countries are mostly developed based on the spike antigens of SARS-CoV-2, which not only is involved in cell receptor recognition and virulence, but also is very antigenic.
کلیدواژه‌ها
COVID؛ 19
سایر فایل های مرتبط با مقاله
مراجع
  1. Negahdaripour M. The Battle Against COVID-19: Where Do We Stand Now? Iran J Med Sci. 2020;45:81-2. doi: 10.30476/ijms.2020.46357. PubMed PMID: 32210483; PubMed Central PMCID: PMCPMC7071545.
  2. Bagheri A, Moezzi SMI, Mosaddeghi P, Nadimi Parashkouhi S, Fazel Hoseini SM, Badakhshan F, et al. Interferon-inducer antivirals: Potential candidates to combat COVID-19. Int Immunopharmacol. 2021;91:107245. doi: 10.1016/j.intimp.2020.107245. PubMed PMID: 33348292; PubMed Central PMCID: PMCPMC7705326.
  3. Owji H, Negahdaripour M, Hajighahramani N. Immunotherapeutic approaches to curtail COVID-19. Int Immunopharmacol. 2020;88:106924. doi: 10.1016/j.intimp.2020.106924. PubMed PMID: 32877828; PubMed Central PMCID: PMCPMC7441891.
  4. Bloom BR, Nowak GJ, Orenstein W. “When Will We Have a Vaccine?” - Understanding Questions and Answers about Covid-19 Vaccination. N Engl J Med. 2020;383:2202-4. doi: 10.1056/NEJMp2025331. PubMed PMID: 32897660.
آمار
تعداد مشاهده مقاله: 2,321
تعداد دریافت فایل اصل مقاله: 1,975


سامانه مدیریت نشریات علمی. قدرت گرفته از سیناوب